Dr. Tagawa Discusses Agents Targeted Against PSMA Targeted Oncology 1:31 9 years ago 256 Далее Скачать
Scott Tagawa, MD, on PSMA Targeting in Prostate Cancer Treatment DocWire 7:17 4 years ago 178 Далее Скачать
Dr. Tagawa on Remaining Questions With PSMA-Targeted Radionuclide Therapy in mCRPC OncLive 1:51 4 years ago 119 Далее Скачать
Dr. Tagawa on BRCA2 in Patients with Prostate Cancer Receiving PSMA-Targeted Radionuclide Therapy OncLive 2:29 5 years ago 464 Далее Скачать
Unanswered questions in PSMA-targeted radionuclide therapy VJOncology 3:02 3 years ago 180 Далее Скачать
Scott Tagawa, MD, on promising PSMA products in development for prostate cancer treatment OBRoncology 1:21 4 years ago 49 Далее Скачать
Dr. Petrylak Discusses PSMA-Directed Therapies in Prostate Cancer Targeted Oncology 1:55 10 years ago 326 Далее Скачать
Scott Tagawa, MD, discusses the results of Phase I dose-escalation study regarding mCRPC OBRoncology 3:25 4 years ago 36 Далее Скачать
56: Prostate-Specific Membrane Antigen (PSMA) -Targeting in Prostate Cancer Treatment – Scott... Garrett D. Pohlman M.D. 27:58 3 years ago 199 Далее Скачать
Dr. Tagawa on CTC in Neuroendocrine-Positive Prostate Cancer OncLive 2:06 10 years ago 352 Далее Скачать
ASCO24 Updates: Innovative 177Lu-PSMA-617 Therapy: Enhanced Survival in Prostate Cancer OncoDaily TV 2:59 6 months ago 80 Далее Скачать
Scott Tagawa, MD, defines the 177Lutethium Beta emitter and the 225Actinium Alpha emitter OBRoncology 2:03 4 years ago 27 Далее Скачать
Scott Tagawa, MD, on the Prostate Cancer Treatment Pipeline DocWire 4:13 4 years ago 138 Далее Скачать
